GlassScriptPhysician profile
Ahadi Hakki
NPI 1194816389
$4,545.49
in general payments reported to CMS, 2019-2025
15 companies · $445 in 2025
The $445 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,413 · 2020: $354 · 2021: $526 · 2022: $1,538 · 2023: $80.64 · 2024: $188 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,391.77 | 2022-2025 | Venapax |
| Atricure, INC. | $1,227.44 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Endologix LLC | $744.90 | 2019-2024 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Ethicon US, LLC | $429.37 | 2020-2025 | Prolene, Stratafix |
| Edwards Lifesciences Corporation | $280.25 | 2019-2025 | Mitris Resilia Mitral Valve |
| Janssen Pharmaceuticals, INC | $110.98 | 2019-2024 | Xarelto |
| Lsi Solutions INC | $78.20 | 2019-2021 | |
| Pulmonx Corporation | $62.64 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Livanova USA, INC. | $61.97 | 2019 | |
| Abiomed | $61.22 | 2023 | Impella |
| W. L. Gore & Associates, INC. | $23.33 | 2019 | |
| Medtronic, INC. | $22.22 | 2024 | Hawkone |
| Altathera Pharmaceuticals LLC | $19.42 | 2023 | Sotalol Hydrochloride |
| Sioux Surgical INC | $16.05 | 2025 | |
| Davol INC. | $15.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahadi Hakki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.